Centessa Pharmaceuticals Acquired by Lilly | Healthcare M&A Deal

Lilly has acquired Centessa Pharmaceuticals, a healthcare services other business in the United Kingdom, for $38.00. Centessa Pharmaceuticals is a healthcare services other company with operations tied to Altrincham, Cheshire, supporting healthcare M&A interest in specialty healthcare. Lilly acquisitions target Centessa’s capabilities to strengthen its healthcare services other portfolio and expand strategic acquisition coverage. The merger acquisition is a strategic acquisition and healthcare M&A announced via a court-sanctioned scheme of arrangement, with deal size over $100M and additional amount noted as $9.00. Lilly acquires Centessa Pharmaceuticals as a strategic acquisition, with shareholder meetings scheduled for June 12, 2026 in London and expected completion after approvals.